---
title: "UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292075597.md"
description: "Today, in Atlanta, on July 8, 2026, UCB, a leading biopharmaceutical firm, unveiled the winners of its yearly UCB Myasthenia Gravis Scholarship. A total of 15 scholarships have been granted to recipients in the United States who are either personally affected by myasthenia gravis (MG) or are caregivers to those with the condition."
datetime: "2026-07-08T13:05:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292075597.md)
  - [en](https://longbridge.com/en/news/292075597.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292075597.md)
---

# UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.

Today, in Atlanta, on July 8, 2026, UCB, a leading biopharmaceutical firm, unveiled the winners of its yearly UCB Myasthenia Gravis Scholarship. A total of 15 scholarships have been granted to recipients in the United States who are either personally affected by myasthenia gravis (MG) or are caregivers to those with the condition.

### Related Stocks

- [UCBJY.US](https://longbridge.com/en/quote/UCBJY.US.md)

## Related News & Research

- [UCB Data Reinforce Long-Term Promise For Weak Muscles Disorder](https://longbridge.com/en/news/292072459.md)
- [UCB partners on meal program for MG patients](https://longbridge.com/en/news/283491345.md)
- [YD Bio launches cancer testing pilot with Numia Health in Canada](https://longbridge.com/en/news/294062286.md)
- [Calidi Biotherapeutics targets Q1 2027 clinic entry for CLD-401 cancer program](https://longbridge.com/en/news/293929420.md)
- [09:01 ETFCANCER CELEBRATES LANDMARK 100TH EVENT WITH DILLON FRANCIS, DIPLO & DJ PAULY D, MARKING YEARS OF IMPACT IN CANCER PREVENTION](https://longbridge.com/en/news/294070677.md)